BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 32665275)

  • 1. New Multidrug Efflux Inhibitors for Gram-Negative Bacteria.
    Marshall RL; Lloyd GS; Lawler AJ; Element SJ; Kaur J; Ciusa ML; Ricci V; Tschumi A; Kühne H; Alderwick LJ; Piddock LJV
    mBio; 2020 Jul; 11(4):. PubMed ID: 32665275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump.
    Grimsey EM; Fais C; Marshall RL; Ricci V; Ciusa ML; Stone JW; Ivens A; Malloci G; Ruggerone P; Vargiu AV; Piddock LJV
    mBio; 2020 Jun; 11(3):. PubMed ID: 32487753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics Reveal Potential Natural Substrates of AcrB in Escherichia coli and Salmonella enterica Serovar Typhimurium.
    Wang-Kan X; Rodríguez-Blanco G; Southam AD; Winder CL; Dunn WB; Ivens A; Piddock LJV
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of natural compound inhibitors for multidrug efflux pumps of Escherichia coli and Pseudomonas aeruginosa using in silico high-throughput virtual screening and in vitro validation.
    Aparna V; Dineshkumar K; Mohanalakshmi N; Velmurugan D; Hopper W
    PLoS One; 2014; 9(7):e101840. PubMed ID: 25025665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cell-based infection assay identifies efflux pump modulators that reduce bacterial intracellular load.
    Reens AL; Crooks AL; Su CC; Nagy TA; Reens DL; Podoll JD; Edwards ME; Yu EW; Detweiler CS
    PLoS Pathog; 2018 Jun; 14(6):e1007115. PubMed ID: 29879224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2019 Garrod Lecture: MDR efflux in Gram-negative bacteria-how understanding resistance led to a new tool for drug discovery.
    Piddock LJV
    J Antimicrob Chemother; 2019 Nov; 74(11):3128-3134. PubMed ID: 31626705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of RamA on the development of ciprofloxacin resistance in Salmonella enterica serovar Typhimurium.
    Sun Y; Dai M; Hao H; Wang Y; Huang L; Almofti YA; Liu Z; Yuan Z
    PLoS One; 2011; 6(8):e23471. PubMed ID: 21858134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.
    Krishnamoorthy G; Leus IV; Weeks JW; Wolloscheck D; Rybenkov VV; Zgurskaya HI
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Throughput Flow Cytometry Screening of Multidrug Efflux Systems.
    Haynes MK; Garcia M; Peters R; Waller A; Tedesco P; Ursu O; Bologa CG; Santos RG; Pinilla C; Wu TH; Lovchik JA; Oprea TI; Sklar LA; Tegos GP
    Methods Mol Biol; 2018; 1700():293-318. PubMed ID: 29177837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of AcrB Efflux Function Confers Loss of Virulence on
    Wang-Kan X; Blair JMA; Chirullo B; Betts J; La Ragione RM; Ivens A; Ricci V; Opperman TJ; Piddock LJV
    mBio; 2017 Jul; 8(4):. PubMed ID: 28720734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput screening of small-molecules libraries identified antibacterials against clinically relevant multidrug-resistant A. baumannii and K. pneumoniae.
    Blasco B; Jang S; Terauchi H; Kobayashi N; Suzuki S; Akao Y; Ochida A; Morishita N; Takagi T; Nagamiya H; Suzuki Y; Watanabe T; Lee H; Lee S; Shum D; Cho A; Koh D; Park S; Lee H; Kim K; Ropponen HK; Augusto da Costa RM; Dunn S; Ghosh S; Sjö P; Piddock LJV
    EBioMedicine; 2024 Apr; 102():105073. PubMed ID: 38520916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of RamA, Which Regulates Production of the Multidrug Resistance Efflux Pump AcrAB-TolC, Increases Mutation Rate and Influences Drug Resistance Phenotype.
    Grimsey EM; Weston N; Ricci V; Stone JW; Piddock LJV
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity.
    Blair JM; Bavro VN; Ricci V; Modi N; Cacciotto P; Kleinekathӧfer U; Ruggerone P; Vargiu AV; Baylay AJ; Smith HE; Brandon Y; Galloway D; Piddock LJ
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3511-6. PubMed ID: 25737552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative reassessment of AcrB efflux inhibitors reveals differential impact of specific pump mutations on the activity of potent compounds.
    Schuster S; Vavra M; Wirth DAN; Kern WV
    Microbiol Spectr; 2024 Feb; 12(2):e0304523. PubMed ID: 38170977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-antibiotics, Efflux Pumps and Drug Resistance of Gram-negative Rods.
    Laudy AE
    Pol J Microbiol; 2018 Jun; 67(2):129-135. PubMed ID: 30015451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of multidrug efflux pump inhibitors with a novel chemical scaffold.
    Green AT; Moniruzzaman M; Cooper CJ; Walker JK; Smith JC; Parks JM; Zgurskaya HI
    Biochim Biophys Acta Gen Subj; 2020 Jun; 1864(6):129546. PubMed ID: 32032658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Acinetobacter baumannii serum-associated antibiotic efflux pump inhibitors.
    Blanchard C; Barnett P; Perlmutter J; Dunman PM
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6360-70. PubMed ID: 25114126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Rules of Efflux Inhibition and Avoidance in Pseudomonas aeruginosa.
    Mehla J; Malloci G; Mansbach R; López CA; Tsivkovski R; Haynes K; Leus IV; Grindstaff SB; Cascella RH; D'Cunha N; Herndon L; Hengartner NW; Margiotta E; Atzori A; Vargiu AV; Manrique PD; Walker JK; Lomovskaya O; Ruggerone P; Gnanakaran S; Rybenkov VV; Zgurskaya HI
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence High-Throughput Screening for Inhibitors of TonB Action.
    Nairn BL; Eliasson OS; Hyder DR; Long NJ; Majumdar A; Chakravorty S; McDonald P; Roy A; Newton SM; Klebba PE
    J Bacteriol; 2017 May; 199(10):. PubMed ID: 28242720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
    Bailey AM; Paulsen IT; Piddock LJ
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3604-11. PubMed ID: 18694955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.